Active, Not Recruiting
A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
NCT01896479
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +16 more
- Locations
-
- St Leonards, New South Wales, Australia
- Herston, Queensland, Australia
- Kurralta Park, South Australia, Australia
- Parkville, Victoria, Australia